Bupivacaine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Bupivacaine Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Feb 20, 2018. Reported reason: Demand increase for the drug
Shortage details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-464-31
- Dosage Form
- Injection
- Presentation
- Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-31)
- Initial Posting
- Feb 20, 2018
Reason
Demand increase for the drug